Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00011622 · ClinicalTrials.gov registry record

Maternal Glucose Measurement in Pregnancy Using a Continuous Ambulatory Subcutaneous Monitor

A clinical trial of Pregnancy, sponsored by National Center for Research Resources (NCRR).

Completed
Registry status
1
Study location

NCT00011622 is a study of Pregnancy that has completed, run by National Center for Research Resources (NCRR). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00011622, a study of Pregnancy, has completed, sponsored by National Center for Research Resources (NCRR).

COMPLETED
Registry status
1
Study location

Study Summary

This proposal is a pilot study to describe the variations of blood sugar in pregnant women with various degrees of glucose intolerance, and how they relate to standardized meals. Blood sugar control during pregnancy is important to prevent complications for the newborn. The variation and timing of the blood sugar measurements in gestational diabetics and how this relates to the baby's outcome is controversial. We will use an FDA approved device called Minimed Glucose Continuous Monitor, which is used in clinical practice for certain diabetics. It is very small, similar to a beeper, and is connected to the patient through a small plastic catheter subcutaneously. This measures blood sugar every five minutes for a total of 288 readings a day with minimum discomfort. The hypothesis of this study is that use of the Minimed glucose monitor will provide information about variations of blood sugar in gestational diabetics that is missed by capillary glucose monitors. Our conclusions will allow us to compare blood glucose trends among the groups. After the data is analyzed in this pilot study, we plan to design a bigger study involving more subjects to study the impact of the blood sugar variations in the outcome of the newborn, and to obtain generalizable results for the population in general.

Conditions Studied

Interventions

  • DEVICE Continuous ambulatory subcutaneous glucose monitor

Study Locations (1)

Texas

  • University of Texas Medical School - Houston

Trial Details

FieldValue

What the Registry Record Tells You About NCT00011622

The ClinicalTrials.gov registry entry for NCT00011622 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Continuous ambulatory subcutaneous glucose monitor is the first listed.

NCT00011622 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00011622 about?

NCT00011622 is a clinical study titled "Maternal Glucose Measurement in Pregnancy Using a Continuous Ambulatory Subcutaneous Monitor". This proposal is a pilot study to describe the variations of blood sugar in pregnant women with various degrees of glucose intolerance, and how they relate to standardized meals. Blood sugar control during pregnancy is important to prevent complications for the newborn. The variation and timing of t...

What is the current status of trial NCT00011622?

This trial is currently completed.

What conditions does trial NCT00011622 study?

This clinical trial studies the following conditions: Pregnancy.

What interventions are being tested in trial NCT00011622?

The interventions under investigation include: Continuous ambulatory subcutaneous glucose monitor (DEVICE).

Who is sponsoring clinical trial NCT00011622?

This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00011622 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.